Synchronous bilateral breast cancer: A case report of heterogeneous estrogen receptor status

INTRODUCTION: Tumour heterogeneity is important in the management of breast cancer. Hormone receptors are established biomarkers for treatment and prognosis of patients with breast cancer. There are three immunohistochemical biomarkers: estrogen receptor (ER), progesterone receptor (PR) and human ep...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhadlie, Sunny, Whitfield, Joseph, Hendahewa, Rasika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6216046/
https://www.ncbi.nlm.nih.gov/pubmed/30391732
http://dx.doi.org/10.1016/j.ijscr.2018.10.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6216046/
https://www.ncbi.nlm.nih.gov/pubmed/30391732
http://dx.doi.org/10.1016/j.ijscr.2018.10.016

Ejemplares similares